285 related articles for article (PubMed ID: 20847559)
1. Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study.
Rusanen M; Rovio S; Ngandu T; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
Dement Geriatr Cogn Disord; 2010; 30(3):277-84. PubMed ID: 20847559
[TBL] [Abstract][Full Text] [Related]
2. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
3. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.
Eskelinen MH; Ngandu T; Tuomilehto J; Soininen H; Kivipelto M
J Alzheimers Dis; 2009; 16(1):85-91. PubMed ID: 19158424
[TBL] [Abstract][Full Text] [Related]
4. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
5. Work-related physical activity and the risk of dementia and Alzheimer's disease.
Rovio S; Kåreholt I; Viitanen M; Winblad B; Tuomilehto J; Soininen H; Nissinen A; Kivipelto M
Int J Geriatr Psychiatry; 2007 Sep; 22(9):874-82. PubMed ID: 17721898
[TBL] [Abstract][Full Text] [Related]
6. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.
Podewils LJ; Guallar E; Kuller LH; Fried LP; Lopez OL; Carlson M; Lyketsos CG
Am J Epidemiol; 2005 Apr; 161(7):639-51. PubMed ID: 15781953
[TBL] [Abstract][Full Text] [Related]
7. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study.
Laitinen MH; Ngandu T; Rovio S; Helkala EL; Uusitalo U; Viitanen M; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
Dement Geriatr Cogn Disord; 2006; 22(1):99-107. PubMed ID: 16710090
[TBL] [Abstract][Full Text] [Related]
8. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
[TBL] [Abstract][Full Text] [Related]
9. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort.
Rönnemaa E; Zethelius B; Lannfelt L; Kilander L
Dement Geriatr Cogn Disord; 2011; 31(6):460-6. PubMed ID: 21791923
[TBL] [Abstract][Full Text] [Related]
10. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
Huriletemuer ; Wang B; Wang J; Wang G; Zhang C; Zhao S; Zhou S; Ma X; Wang de S
J Neurol Sci; 2010 Jan; 288(1-2):167-9. PubMed ID: 19819468
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism and dementia: a hospital-based study from southern India.
Bharath S; Purushottam M; Mukherjee O; Bagepally BS; Prakash O; Kota L; Krishnappa SB; Sivakumar PT; Jain S; Varghese M
Dement Geriatr Cogn Disord; 2010; 30(6):455-60. PubMed ID: 21252538
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
[TBL] [Abstract][Full Text] [Related]
13. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.
Ponomareva NV; Korovaitseva GI; Rogaev EI
Neurobiol Aging; 2008 Jun; 29(6):819-27. PubMed ID: 17293007
[TBL] [Abstract][Full Text] [Related]
14. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
Klages J; Fisk JD
Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
[TBL] [Abstract][Full Text] [Related]
15. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
[TBL] [Abstract][Full Text] [Related]
16. Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study.
Rusanen M; Kivipelto M; Levälahti E; Laatikainen T; Tuomilehto J; Soininen H; Ngandu T
J Alzheimers Dis; 2014; 42(1):183-91. PubMed ID: 24825565
[TBL] [Abstract][Full Text] [Related]
17. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
18. Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia.
Fehér A; Juhász A; Rimanóczy A; Csibri E; Kálmán J; Janka Z
Dement Geriatr Cogn Disord; 2009; 28(1):56-62. PubMed ID: 19641318
[TBL] [Abstract][Full Text] [Related]
19. Experience of ApoE study in Thai elderly.
Senanarong V; Harnphadungkit K; Lertrit P; Mitrpant C; Udompunthurak S; Limwong C; Prayoonwiwat N; Poungvarin N
J Med Assoc Thai; 2001 Feb; 84(2):182-7. PubMed ID: 11336076
[TBL] [Abstract][Full Text] [Related]
20. [Apolipoprotein E genotypes in patients investigated for dementia].
Johannsen P; Jakobsen JK; Jørgensen AL
Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
